In transgenic Apc+/∆716/Smad4+/- compound knockout mice that develop CRC, CCL9 is secreted from cancer cells, which recruits CCR1+ myeloid cells to promote tumor invasion [10]. Here, SMAD4 is linked to neoplasm.